As of 2026-04-01, the EV/EBITDA ratio of Vera Therapeutics Inc (VERA) is -. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VERA's latest enterprise value is 2,590.93 mil USD. VERA's TTM EBITDA according to its financial statements is - mil USD. Dividing these 2 quantities gives us the above VERA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |